PMID- 32306805 OWN - NLM STAT- MEDLINE DCOM- 20210604 LR - 20210604 IS - 1549-781X (Electronic) IS - 1040-8363 (Linking) VI - 57 IP - 7 DP - 2020 Nov TI - Perspectives on the role of PTEN in diabetic nephropathy: an update. PG - 470-483 LID - 10.1080/10408363.2020.1746735 [doi] AB - Phosphatase and tensin homolog (PTEN) is a potent tumor suppressor gene that antagonizes the proto-oncogenic phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt) signaling pathway and governs basic cellular metabolic processes. Recently, its role in cell growth, metabolism, architecture, and motility as an intramolecular and regulatory mediator has gained widespread research interest as it applies to non-tumorous diseases, such as insulin resistance (IR) and diabetic nephropathy (DN). DN is characterized by renal tubulointerstitial fibrosis (TIF) and epithelial-mesenchymal transition (EMT), and PTEN plays a significant role in the regulation of both. Epigenetics and microRNAs (miRNAs) are novel players in post-transcriptional regulation and research evidence demonstrates that they reduce the expression of PTEN by acting as key regulators of autophagy and TIF through activation of the Akt/mammalian target of rapamycin (mTOR) signaling pathway. These regulatory processes might play an important role in solving the complexities of DN pathogenesis and IR, as well as the therapeutic management of DN with the help of PTEN K27-linked polyubiquitination. Currently, there are no comprehensive reviews citing the role PTEN plays in the development of DN and its regulation via miRNA and epigenetic modifications. The present review explores these facets of PTEN in the pathogenesis of IR and DN. FAU - Khokhar, Manoj AU - Khokhar M AD - Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India. FAU - Roy, Dipayan AU - Roy D AD - Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India. FAU - Modi, Anupama AU - Modi A AD - Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India. FAU - Agarwal, Riddhi AU - Agarwal R AD - Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India. FAU - Yadav, Dharmveer AU - Yadav D AD - Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India. FAU - Purohit, Purvi AU - Purohit P AUID- ORCID: 0000-0001-8559-2911 AD - Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India. FAU - Sharma, Praveen AU - Sharma P AUID- ORCID: 0000-0002-8324-737X AD - Department of Biochemistry, All India Institute of Medical Sciences, Jodhpur, India. LA - eng PT - Journal Article PT - Review DEP - 20200420 PL - England TA - Crit Rev Clin Lab Sci JT - Critical reviews in clinical laboratory sciences JID - 8914816 RN - 0 (MicroRNAs) RN - EC 2.7.11.1 (AKT1 protein, human) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 3.1.3.67 (PTEN Phosphohydrolase) RN - EC 3.1.3.67 (PTEN protein, human) SB - IM MH - Autophagy/genetics MH - Diabetic Nephropathies/*metabolism/physiopathology MH - Epigenesis, Genetic/genetics MH - Epithelial-Mesenchymal Transition/genetics MH - Female MH - Fibrosis/genetics MH - Humans MH - Insulin Resistance/*genetics MH - Male MH - MicroRNAs/genetics MH - PTEN Phosphohydrolase/genetics/*metabolism/physiology MH - Phosphatidylinositol 3-Kinases/metabolism MH - Proto-Oncogene Proteins c-akt/metabolism MH - Signal Transduction OTO - NOTNLM OT - Diabetic nephropathy OT - EMT OT - PI3K OT - Type 2 diabetes mellitus OT - insulin resistance EDAT- 2020/04/21 06:00 MHDA- 2021/06/05 06:00 CRDT- 2020/04/21 06:00 PHST- 2020/04/21 06:00 [pubmed] PHST- 2021/06/05 06:00 [medline] PHST- 2020/04/21 06:00 [entrez] AID - 10.1080/10408363.2020.1746735 [doi] PST - ppublish SO - Crit Rev Clin Lab Sci. 2020 Nov;57(7):470-483. doi: 10.1080/10408363.2020.1746735. Epub 2020 Apr 20.